Phase Scientific is a diagnostic technology company specializing in home-based and lab testing solutions powered by its proprietary PHASIFY® technology, which enhances DNA detection from urine, saliva, and plasma. After generating significant revenue from COVID-19 products, the company has pivoted to focus on INDICAID rapid tests, women’s health, and cancer diagnostics. Its non-invasive, easy-to-use tests address barriers like discomfort and privacy, improving screening compliance. By enabling early detection and chronic disease monitoring, Phase Scientific helps reduce hospital dependency and supports preventive care. It is also developing a digital health platform aligned with the global shift toward personalized, at-home healthcare.